Emanuel Moisa, Georgeana Tuculeanu, Liliana Mirea, Claudia Mihail, Stefanita Dima, Liviu Ioan Serban, Dan Corneci, Federico Bilotta, Silvius Ioan Negoita
{"title":"血球/血红蛋白比值作为需要神经外科或血管内治疗的动脉瘤性蛛网膜下腔出血危重患者住院死亡率和延迟性脑缺血的新的独立预测指标:回顾性分析","authors":"Emanuel Moisa, Georgeana Tuculeanu, Liliana Mirea, Claudia Mihail, Stefanita Dima, Liviu Ioan Serban, Dan Corneci, Federico Bilotta, Silvius Ioan Negoita","doi":"10.1007/s12028-025-02395-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Substantial research has been dedicated to new prognostication tools in aneurysmal subarachnoid hemorrhage (aSAH), with a recent focus on laboratory parameters. Our study investigates the predictive value of a new hematological index, the hematocrit-to-hemoglobin (Ht-to-Hb) ratio, for mortality and delayed cerebral ischemia (DCI).</p><p><strong>Methods: </strong>This is a retrospective, single-center, observational study on 78 adult critically ill patients with aSAH. We collected data from the electronic and written records, including demographic and clinical data, therapeutic measures, and intensive care unit and hospital length of stay. The primary outcome was in-hospital mortality, whereas the secondary outcome was DCI development. After descriptive analysis was performed, the Ht-to-Hb ratio was tested as a predictor for the primary and secondary outcomes. Firstly, we conducted a receiver operating characteristic analysis, and cutoff values were identified using the Youden index. Further, in-hospital mortality and DCI probability were evaluated using the log rank test. Cox proportional hazards regression was conducted to test the independent predictive value of the Ht-to-Hb ratio for the aforementioned outcomes.</p><p><strong>Results: </strong>Mortality during hospitalization was 25.54%, whereas DCI frequency was 42.3%. The Ht-to-Hb ratio had areas under the receiver operating characteristic curve for death prediction and DCI of 0.85 and 0.734, respectively. Values greater than the cutoff value for mortality, 3.069, were independently associated with the primary outcome in the multivariable analysis (hazard ratio [HR] 4.64, 95% confidence interval [CI] 1.08-19.98, p = 0.039). For DCI, the cutoff value identified was 3.007. Ht-to-Hb ratios > 3.007 were an independent risk factor for DCI in the multivariable analysis (HR 3.86, 95% CI 1.43-10.4, p = 0.008).</p><p><strong>Conclusions: </strong>The present study proposes a new prognostic index for mortality and DCI in aSAH: the Ht-to-Hb ratio. This marker could act as a surrogate for blood viscosity, uncovering the importance of blood rheology in aSAH pathogenesis.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hematocrit-to-Hemoglobin Ratio as a Novel Independent Predictor for In-Hospital Mortality and Delayed Cerebral Ischemia in Critically Ill Patients with Aneurysmal Subarachnoid Hemorrhage Requiring Neurosurgical or Endovascular Treatment: A Retrospective Analysis.\",\"authors\":\"Emanuel Moisa, Georgeana Tuculeanu, Liliana Mirea, Claudia Mihail, Stefanita Dima, Liviu Ioan Serban, Dan Corneci, Federico Bilotta, Silvius Ioan Negoita\",\"doi\":\"10.1007/s12028-025-02395-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Substantial research has been dedicated to new prognostication tools in aneurysmal subarachnoid hemorrhage (aSAH), with a recent focus on laboratory parameters. Our study investigates the predictive value of a new hematological index, the hematocrit-to-hemoglobin (Ht-to-Hb) ratio, for mortality and delayed cerebral ischemia (DCI).</p><p><strong>Methods: </strong>This is a retrospective, single-center, observational study on 78 adult critically ill patients with aSAH. We collected data from the electronic and written records, including demographic and clinical data, therapeutic measures, and intensive care unit and hospital length of stay. The primary outcome was in-hospital mortality, whereas the secondary outcome was DCI development. After descriptive analysis was performed, the Ht-to-Hb ratio was tested as a predictor for the primary and secondary outcomes. Firstly, we conducted a receiver operating characteristic analysis, and cutoff values were identified using the Youden index. Further, in-hospital mortality and DCI probability were evaluated using the log rank test. Cox proportional hazards regression was conducted to test the independent predictive value of the Ht-to-Hb ratio for the aforementioned outcomes.</p><p><strong>Results: </strong>Mortality during hospitalization was 25.54%, whereas DCI frequency was 42.3%. The Ht-to-Hb ratio had areas under the receiver operating characteristic curve for death prediction and DCI of 0.85 and 0.734, respectively. Values greater than the cutoff value for mortality, 3.069, were independently associated with the primary outcome in the multivariable analysis (hazard ratio [HR] 4.64, 95% confidence interval [CI] 1.08-19.98, p = 0.039). For DCI, the cutoff value identified was 3.007. Ht-to-Hb ratios > 3.007 were an independent risk factor for DCI in the multivariable analysis (HR 3.86, 95% CI 1.43-10.4, p = 0.008).</p><p><strong>Conclusions: </strong>The present study proposes a new prognostic index for mortality and DCI in aSAH: the Ht-to-Hb ratio. This marker could act as a surrogate for blood viscosity, uncovering the importance of blood rheology in aSAH pathogenesis.</p>\",\"PeriodicalId\":19118,\"journal\":{\"name\":\"Neurocritical Care\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-10-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurocritical Care\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12028-025-02395-x\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurocritical Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12028-025-02395-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:大量研究致力于动脉瘤性蛛网膜下腔出血(aSAH)的新预测工具,最近的重点是实验室参数。我们的研究探讨了一种新的血液学指标,红细胞与血红蛋白(Ht-to-Hb)比率对死亡率和延迟性脑缺血(DCI)的预测价值。方法:对78例成人aSAH危重患者进行回顾性、单中心、观察性研究。我们从电子和书面记录中收集数据,包括人口统计和临床数据、治疗措施、重症监护病房和住院时间。主要结局是住院死亡率,而次要结局是DCI发展。描述性分析完成后,测试ht - hb比率作为主要和次要结局的预测因子。首先,我们进行了接收机工作特性分析,并利用约登指数确定了截止值。此外,采用对数秩检验评估住院死亡率和DCI概率。采用Cox比例风险回归检验ht - hb比值对上述结果的独立预测值。结果:住院期间死亡率为25.54%,DCI发生率为42.3%。ht - hb比值在死亡预测的受试者工作特征曲线下面积和DCI分别为0.85和0.734。在多变量分析中,死亡率的临界值大于3.069与主要结局独立相关(风险比[HR] 4.64, 95%可信区间[CI] 1.08-19.98, p = 0.039)。对于DCI,确定的截止值为3.007。在多变量分析中,ht - hb比值bbb3.007是DCI的独立危险因素(HR 3.86, 95% CI 1.43-10.4, p = 0.008)。结论:本研究提出了一种新的预测aSAH死亡率和DCI的指标:ht - hb比值。该标志物可作为血液粘度的替代指标,揭示了血液流变学在aSAH发病机制中的重要性。
Hematocrit-to-Hemoglobin Ratio as a Novel Independent Predictor for In-Hospital Mortality and Delayed Cerebral Ischemia in Critically Ill Patients with Aneurysmal Subarachnoid Hemorrhage Requiring Neurosurgical or Endovascular Treatment: A Retrospective Analysis.
Background: Substantial research has been dedicated to new prognostication tools in aneurysmal subarachnoid hemorrhage (aSAH), with a recent focus on laboratory parameters. Our study investigates the predictive value of a new hematological index, the hematocrit-to-hemoglobin (Ht-to-Hb) ratio, for mortality and delayed cerebral ischemia (DCI).
Methods: This is a retrospective, single-center, observational study on 78 adult critically ill patients with aSAH. We collected data from the electronic and written records, including demographic and clinical data, therapeutic measures, and intensive care unit and hospital length of stay. The primary outcome was in-hospital mortality, whereas the secondary outcome was DCI development. After descriptive analysis was performed, the Ht-to-Hb ratio was tested as a predictor for the primary and secondary outcomes. Firstly, we conducted a receiver operating characteristic analysis, and cutoff values were identified using the Youden index. Further, in-hospital mortality and DCI probability were evaluated using the log rank test. Cox proportional hazards regression was conducted to test the independent predictive value of the Ht-to-Hb ratio for the aforementioned outcomes.
Results: Mortality during hospitalization was 25.54%, whereas DCI frequency was 42.3%. The Ht-to-Hb ratio had areas under the receiver operating characteristic curve for death prediction and DCI of 0.85 and 0.734, respectively. Values greater than the cutoff value for mortality, 3.069, were independently associated with the primary outcome in the multivariable analysis (hazard ratio [HR] 4.64, 95% confidence interval [CI] 1.08-19.98, p = 0.039). For DCI, the cutoff value identified was 3.007. Ht-to-Hb ratios > 3.007 were an independent risk factor for DCI in the multivariable analysis (HR 3.86, 95% CI 1.43-10.4, p = 0.008).
Conclusions: The present study proposes a new prognostic index for mortality and DCI in aSAH: the Ht-to-Hb ratio. This marker could act as a surrogate for blood viscosity, uncovering the importance of blood rheology in aSAH pathogenesis.
期刊介绍:
Neurocritical Care is a peer reviewed scientific publication whose major goal is to disseminate new knowledge on all aspects of acute neurological care. It is directed towards neurosurgeons, neuro-intensivists, neurologists, anesthesiologists, emergency physicians, and critical care nurses treating patients with urgent neurologic disorders. These are conditions that may potentially evolve rapidly and could need immediate medical or surgical intervention. Neurocritical Care provides a comprehensive overview of current developments in intensive care neurology, neurosurgery and neuroanesthesia and includes information about new therapeutic avenues and technological innovations. Neurocritical Care is the official journal of the Neurocritical Care Society.